Well established examples include KIT mutations which are present in ~ 85% of gastro-intestinal stromal tumors [1], EGFR mutations that have been identified in ~ 15% of non-small cell lung cancers [2], and lung and colorectal cancers with mutations in the KRAS oncogene [3]. This evidence concerns the gene EGFR and colorectal cancer.